Influenza A Virus Hemagglutinin Antibody (IV.C102) is a mouse monoclonal IgG1 antibody that detects Influenza A Virus Hemagglutinin by western blotting (WB) and immunofluorescence (IF). Influenza A Virus Hemagglutinin (clone IV.C102) antibody recognizes a protein crucial for viral infection of host cells through binding to sialic acid-containing receptors on respiratory tract epithelial cells. Anti-Influenza A Virus Hemagglutinin antibody (IV.C102) targets a protein that undergoes key conformational changes during receptor binding, enabling viral and cellular membrane fusion. Understanding these structural dynamics aids in antiviral drug design and vaccine development, as Influenza A Virus Hemagglutinin is central to immune responses against influenza infections. Influenza A Virus Hemagglutinin monoclonal antibody (IV.C102) serves as a valuable research tool for studying viral infection mechanisms and host immune responses.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Influenza A Virus Hemagglutinin Antibody (IV.C102) References:
- Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions. | Marsh, GA., et al. 2007. J Virol. 81: 9727-36. PMID: 17634232
- In vivo biotinylated recombinant influenza A virus hemagglutinin for use in subtype-specific serodiagnostic assays. | Postel, A., et al. 2011. Anal Biochem. 411: 22-31. PMID: 21172299
- Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. | Hensley, SE., et al. 2011. PLoS One. 6: e15190. PMID: 21364978
- Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines. | Xuan, C., et al. 2011. Protein Cell. 2: 997-1005. PMID: 22231357
- Binding kinetics of sulfatide with influenza A virus hemagglutinin. | Takahashi, T., et al. 2013. Glycoconj J. 30: 709-16. PMID: 23604989
- Influenza A virus hemagglutinin and neuraminidase mutually accelerate their apical targeting through clustering of lipid rafts. | Ohkura, T., et al. 2014. J Virol. 88: 10039-55. PMID: 24965459
- Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes. | Fan, X., et al. 2015. Mucosal Immunol. 8: 211-20. PMID: 25052763
- The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases. | Kühn, N., et al. 2016. J Virol. 90: 4298-4307. PMID: 26889029
- Influenza A Virus Hemagglutinin is Required for the Assembly of Viral Components Including Bundled vRNPs at the Lipid Raft. | Takizawa, N., et al. 2016. Viruses. 8: PMID: 27626438
- Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms. | Kosik, I. and Yewdell, JW. 2017. Virology. 500: 178-183. PMID: 27825034